CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro

References

• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
   PubMed Web of Science ®Google Scholar
• Collins RJ, Verschuer LA, Harmon BV, . Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 1989;71:343–350.
   PubMed Web of Science ®Google Scholar
• O’Brien S, Kay NE. Maintenance therapy for B-chronic lymphocytic leukemia. Clin Adv Hematol Oncol 2011;9:22–31.
   PubMedGoogle Scholar
• Munk Pedersen I, Reed J. Microenvironmental interactions and survival of CLL B-cells. Leuk Lymphoma 2004;45:2365–2372.
   PubMed Web of Science ®Google Scholar
• Hayden RE, Pratt G, Roberts C, . Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leuk Lymphoma 2011 Sep 23. [Epub ahead of print]
   Web of Science ®Google Scholar
• Messmer BT, Messmer D, Allen SL, . In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005;115:755–764.
   PubMed Web of Science ®Google Scholar
• van Gent R, Kater AP, Otto SA, . In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. Cancer Res 2008;68:10137–10144.
   PubMed Web of Science ®Google Scholar
• Schillaci R, Galeano A, Becu-Villalobos D, . Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia. Br J Haematol 2005;130:58–66.
   PubMed Web of Science ®Google Scholar
• Dancescu M, Rubio-Trujillo M, Biron G, . Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 1992;176:1319–1326.
   PubMed Web of Science ®Google Scholar
• Francia di Celle P, Mariani S, Riera L, . Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996;87:4382–4389.
   PubMed Web of Science ®Google Scholar
• Chaouchi N, Wallon C, Goujard C, . Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 1996;87:1022–1029.
   PubMed Web of Science ®Google Scholar
• Burger JA, Quiroga MP, Hartmann E, . High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 2009;113:3050–3058.
   PubMed Web of Science ®Google Scholar
• Ticchioni M, Essafi M, Jeandel PY, . Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 2007;26:7081–7091.
   PubMed Web of Science ®Google Scholar
• Pedersen IM, Kitada S, Leoni LM, . Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2002;100:1795–1801.
   PubMed Web of Science ®Google Scholar
• Kay NE, Shanafelt TD, Strege AK, . Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch”. Leuk Res 2007;31:899–906.
   PubMed Web of Science ®Google Scholar
• Panayiotidis P, Jones D, Ganeshaguru K, . Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1996;92:97–103.
   PubMed Web of Science ®Google Scholar
• Burger JA, Tsukada N, Burger M, . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000;96:2655–2663.
   PubMed Web of Science ®Google Scholar
• Gamberale R, Geffner J, Arrosagaray G, . Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 2001;15:1860–1867.
   PubMed Web of Science ®Google Scholar
• Levesque MC, O’Loughlin CW, Weinberg JB. Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture. Leukemia 2001;15:1305–1307.
   PubMed Web of Science ®Google Scholar
• Seiffert M, Schulz A, Ohl S, . Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo. Blood 2010;116:4223–4230.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Grever M, . National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
   PubMed Web of Science ®Google Scholar
• Kurtova AV, Balakrishnan K, Chen R, . Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009;114:4441–4450.
   PubMed Web of Science ®Google Scholar
• Moreno A, Villar ML, Camara C, . Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood 2001;97:242–249.
   PubMed Web of Science ®Google Scholar
• Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 2006;25:357–3571.
   PubMed Web of Science ®Google Scholar
• Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143–154.
   PubMed Web of Science ®Google Scholar
• Bomstein Y, Yuklea M, Radnay J, . The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia. Eur J Haematol 2003;70:290–295.
   PubMed Web of Science ®Google Scholar
• Raman D, Baugher PJ, Thu YM, . Role of chemokines in tumor growth. Cancer Lett 2007;256:137–165.
   PubMed Web of Science ®Google Scholar
• Diaz-Guerra E, Vernal R, del Prete MJ, . CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional T cells. J Immunol 2007;179:7352–7357.
   PubMed Web of Science ®Google Scholar
• Tarzami ST, Calderon TM, Deguzman A, . MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway. Biochem Biophys Res Commun 2005;335:1008–1016.
   PubMed Web of Science ®Google Scholar
• Pinto LA, Williams MS, Dolan MJ, . Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals. Eur J Immunol 2000;30:2048–2055.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Kabashima K, Nakamura M, . Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes. Skin Pharmacol Physiol 2009;22:45–48.
   PubMed Web of Science ®Google Scholar
• Lai R, O’Brien S, Maushouri T, . Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer 2002;95:1071–1075.
   PubMed Web of Science ®Google Scholar
• Biswas P, Delfanti F, Bernasconi S, . Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998;91:258–265.
   PubMed Web of Science ®Google Scholar
• Ghia P, Strola G, Granziero L, . Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4 +, CD40L + T cells by producing CCL22. Eur J Immunol 2002;32:1403–1413.
   PubMed Web of Science ®Google Scholar
• Barretina J, Junca J, Llano A, . CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease. Ann Hematol 2003;82:500–505.
   PubMed Web of Science ®Google Scholar
• Burger M, Hartmann T, Krome M, . Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005;106:1824–1830.
   PubMed Web of Science ®Google Scholar
• Rojas R, Roman J, Torres A, . Inhibition of apoptotic cell death in B-CLL by interferon gamma correlates with clinical stage. Leukemia 1996;10:1782–1788.
   PubMed Web of Science ®Google Scholar
• Chunsong H, Yuling H, Li W, . CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23 + CD5 + B cells. J Immunol 2006;177:6713–6722.
   PubMed Web of Science ®Google Scholar
• Lagneaux L, Delforge A, Bron D, . Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 1998;91:2387–2396.
   PubMed Web of Science ®Google Scholar
• Burkle A, Niedermeier M, Schmitt-Graff A, . Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007;110:3316–3325.
   PubMed Web of Science ®Google Scholar
• Zucchetto A, Benedetti D, Tripodo C, . CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res 2009;69:4001–4009.
   PubMed Web of Science ®Google Scholar